Contract 75N98020F00059
Life Technologies Corporation · Department Of Health And Human Services · February 24, 2020
Life Technologies Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on February 24, 2020 for $21,000 of work in biological product (except diagnostic) manufacturing. Performance is in Carlsbad, CA. This is a task or delivery order issued under parent IDIQ HHSN263201200063B. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 17, 2020.
Contract details
- PIID
- 75N98020F00059
- Parent IDIQ
- HHSN263201200063B
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Carlsbad, CA
- First action
- February 24, 2020
- Latest action
- September 17, 2020
Description
ENZYMES
Modification timeline
-
September 17, 2020Mod P00001$-885
-
June 8, 2020Base awardBOXES$9.9K
-
February 24, 2020Base award$12.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N98020F00059?
Contract 75N98020F00059 is a federal contract awarded to Life Technologies Corporation by Department Of Health And Human Services on February 24, 2020 for $21,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N98020F00059?
Life Technologies Corporation won contract 75N98020F00059 from Department Of Health And Human Services.
How much is contract 75N98020F00059 worth?
Contract 75N98020F00059 has obligated $21,000 to date.